Back HCV Populations

HCV Populations

Opioid Maintenance Therapy Linked to Lower Hepatitis C Rates for People Who Inject Drugs

Young drug injectors who undergo opioid agonist maintenance therapy using buprenorphine or methadone have a lower likelihood of becoming infected with hepatitis C virus (HCV) than those who continue injecting or use other types of substance use treatment, according to a study published in the October 27 edition of JAMA Internal Medicine.

alt

Read more:

EACS 2013: HCV Reinfection Common Among HIV Positive Gay Men in Europe

A study found that 18% of HIV positive men acquired hepatitis C virus (HCV) a second time after clearing the virus, with some having third and fourth infections as well, according to findings from the European AIDS Treatment Network presented at the 14th European AIDS Conference this month in Brussels.

alt

Read more:

National Medical Association Releases Report on Hepatitis C Among African Americans

The National Medical Association, the largest medical organization representing African American physicians and their patients, has issued a new report on hepatitis C virus (HCV) infection among Black Americans, emphasizing the need for increased awareness, more screening of this population, and broader inclusion of African Americans in clinical trials.

alt

Read more:

Hepatitis C Prevention and Management for People Who Inject Drugs

People who inject drugs can benefit from hepatitis C prevention efforts and antiviral treatment, but comprehensive programs may be needed to help overcome a variety of challenges, according to a special supplement of Clinical Infectious Diseases entitled "Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward." The International Network on Hepatitis in Substance Users is holding its biennial symposium this week in Munich.

alt

Read more:

Hepatitis C Incidence Rises among HIV+ Gay Men in Swiss Study

Sexually transmitted hepatitis C virus (HCV) infection has increased dramatically over the past 13 years among gay and bisexual men in the Swiss HIV Cohort Study, even as it remained stable among heterosexuals and decreased among injection drug users, investigators reported in the November 2012 issue of Clinical Infectious Diseases.alt

Read more: